Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma

There is no effective treatment for recurrent glioblastoma (GB) when temozolomide-based radiochemotherapy fails. In theory, intra-arterial (IA) delivery of cytotoxic agents could achieve higher drug concentrations in tumors compared to intravenous injection. Moreover, choosing a highly lipid-soluble...

Full description

Bibliographic Details
Main Authors: Mohamad Chehimi, Mathieu Boone, Cyril Chivot, Hervé Deramond, Jean-Marc Constans, Mony Chenda Ly, Bruno Chauffert
Format: Article
Language:English
Published: Karger Publishers 2016-08-01
Series:Case Reports in Oncology
Subjects:
Idarubicin
Intra-arterial chemotherapy
Glioblastoma
Online Access:http://www.karger.com/Article/FullText/448654

Similar Items

Similar Items